In order to compare the multiple-dose bioavailability of carbamazepine (CBZ) from 2 slow-release preparations, Neurotol slow and Tegretol Retard, a single-blind, randomized, cross-over study was carried out. 21 adult patients with epilepsy were enrolled in the study. At the end of both 2-week treatm
Comparison of the bioavailability of two slow release preparations of disopyramide
β Scribed by M. G. Bogaert; F. Belpaire; G. Wilde; R. A. Lefebvre
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 184 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
β¦ Synopsis
The bioavailability of two slow release preparations of disopyramide has been compared in a randomized cross-over trial of Rythmodan L.A. 250 mg b.d. and Dirytmin Durettes 300 mg b.d., given to 10 healthy volunteers. The plasma concentrations of disopyramide were measured on the 5th day of each treatment period. With both preparations, plasma concentrations were well sustained. The amount absorbed was slightly lower after Rythmodan L.A. than after Dirytmin Durettes, but the fluctuations over a dosing interval were significantly more pronounced for Dirytmin Durettes than for Rythmodan L.A.
π SIMILAR VOLUMES
## Abstract In a random crossβover study, eight healthy volunteers received single 10 mg doses of either nifedipine capsule (Adalat, Bayer) or nifedipine tablets (Taro) after an overnight fast. The areas under the serum concentration time curves were not significantly different (AUC^0β β^ 319Β·8 Β± 2